Covid 19 Rapid Antibody Test Kit Suppliers & Bulk Manufacturers

Available Forms: Test Kits

Available Strengths: 1 test/kit, 10 tests/kit

Reference Brands: Cellex qSARS-CoV-2 IgG/IgM Rapid Test (USA), Roche SARS-CoV-2 Rapid Antibody Test (EU)

Category: Rapid Test Kits

The device is designed to aid in the rapid differential diagnosis of COVID-19 Virus infection. This assay is intended to be used for screening patients with suspected COVID-19 Ag infection having symptoms of respiratory infections or immediate contact with confirmed positive cases. Covid 19 Rapid Antibody Test Kit is available in Test Kits and strengths such as 1 test/kit, 10 tests/kit. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Covid 19 Rapid Antibody Test Kit is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Covid 19 Rapid Antibody Test Kit can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, spread rapidly across more than 185 countries and regions, leading to a global health crisis. Within a short period, it resulted in millions of confirmed infections and a significant number of deaths, highlighting its high transmissibility and public health impact. The virus primarily targets the respiratory system, causing illnesses that range from mild symptoms such as fever, cough, and fatigue to severe complications including pneumonia, acute respiratory distress syndrome (ARDS), and multi-organ failure.

SARS-CoV-2 is transmitted mainly through respiratory droplets and close human contact, making containment challenging, especially in densely populated areas. Vulnerable populations, including the elderly and individuals with underlying health conditions, are at a higher risk of severe disease outcomes. The rapid spread and severity of infection have placed immense pressure on healthcare systems worldwide.

Respiratory diseases caused by SARS-CoV-2 continue to pose serious threats to human health, emphasizing the importance of early detection, preventive measures, vaccination, and effective diagnostic tools to control and manage the spread of infection.